Heres how to prep like a pro: 1
Weight loss with tirzepatidean incretin-based agent that activates two hormones that influence appetite, food intake, and metabolic function: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)was associated with significant improvements in various cardiometabolic risk factors, including blood pressure, lipid levels, and glycemic measures
135,148 Clinical studies have shown that sitagliptin, when added to standard-of-care medication, was associated with significant clinical improvement and reduced mortality compared to standard-of-care alone
Although it shares the active ingredient with some weight loss drugs, Ozempic is specifically intended for diabetes control and is not approved for weight loss
While brand-name options assure FDA approval, compounded versions may offer cost-effective and accessible alternatives